Abiopharma

New Form 4 - Unicycive Therapeutics, Inc. Filed: 2025-07-30 AccNo: 0001213900-25-069301 Size: 5 KB

New Form 4 - Unicycive Therapeutics, Inc. Filed: 2025-07-30 AccNo: 0001213900-25-069300 Size: 5 KB

New Form 4 - Unicycive Therapeutics, Inc. Filed: 2025-07-30 AccNo: 0001213900-25-069302 Size: 5 KB

New Form 4 - Liquidia Corp Filed: 2025-07-30 AccNo: 0001104659-25-072192 Size: 5 KB

New Form 4 - Medtronic plc Filed: 2025-07-30 AccNo: 0001613103-25-000118 Size: 10 KB

New Form 4 - Unicycive Therapeutics, Inc. Filed: 2025-07-30 AccNo: 0001213900-25-069305 Size: 5 KB

New Form 4 - Unicycive Therapeutics, Inc. Filed: 2025-07-30 AccNo: 0001213900-25-069306 Size: 5 KB

New Form 4 - Candel Therapeutics, Inc. Filed: 2025-07-30 AccNo: 0000950170-25-100320 Size: 8 KB

How to Apply Thermal Paste Correctly for Optimal CPU Cooling

Coherent Corp. Announces Timing of FY2025 Fourth-Quarter and Fiscal Year-End Earnings Release

STERIS Raises Dividend to $0.63 per share

Travere Therapeutics to Report Second Quarter 2025 Financial Results

New Form 10-Q - TransMedics Group, Inc. Filed: 2025-07-30 AccNo: 0000950170-25-100314 Size: 9 MB

New Form 4 - Medtronic plc Filed: 2025-07-30 AccNo: 0001613103-25-000117 Size: 424 KB

New Form 4 - Medtronic plc Filed: 2025-07-30 AccNo: 0001613103-25-000116 Size: 423 KB